Tech Blog

Convexia

Last verified 2026-09-25. JSON

The funding figures on this page are attributed, not sourced: a publisher is on record but no document URL is. How we mark provenance.

Total raised$1.0Mattributed
Latest roundseed, $1.0M, 2025-06-01attributed
Founded2025
HeadquartersUS
Industryhealthtech
Stageseed
Websiteconvexia.bio

AI drug-discovery platform sourcing overlooked pharmaceutical assets with 50+ custom-tuned models for binding, tox, ADME, and market analysis. Sold to biotech, pharma, and investor groups running drug-asset diligence. Stanford and Y Combinator-backed; modular agents under expert review.

Funding rounds

DateRoundAmountLead
2025-06-01seed$1.0Mundisclosed

Detected tech stack

Cloudflare, AitThemes, LottieFiles 5.12.2, Google Analytics, Google Tag Manager, DoubleClick Floodlight, Webflow, WordPress, PHP, MySQL, jquery 3.5.1

Provenance

FactStatusBasis
Seed, $1.0Mattributedyc named as publisher. No document URL on file.
Total raised $1.0Mattributedyc named as publisher. No document URL on file.
Company existencesourcedY Combinator named as publisher. Document, retrieved 2026-09-17.
Descriptionself-reportedconvexia.bio, read 2026-09-25

Change history

Date
2026-09-24Existence: self-reported → sourced, Y Combinator, document, retrieved 2026-09-17

Records begin 2026-09-24. All changes